ASHPOfficial
It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits

It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits

January 24, 2022

In this feature from the 2021 Specialty Pharmacy Conference, It’s Complicated: Financial and Billing Considerations for Managing Pharmacy and Medical Benefits, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss key strategies to improve payer access and financial management of specialty pharmacy operations. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Managing Biosimilars: A Specialty All Its Own

Managing Biosimilars: A Specialty All Its Own

January 21, 2022

In this feature from the 2021 Specialty Pharmacy Conference: Managing Biosimilars: A Specialty All Its Own, our content matter experts from the ASHP Section of Specialty Pharmacy Practitioners discuss strategies to evaluate and optimize biosimilars in your health-system and specialty practice.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

What you might have missed in 2021: Highlights from the New Clinical Practice Guideline for Management of Pediatric Patients with Acute Hematogenous Osteomyelitis

What you might have missed in 2021: Highlights from the New Clinical Practice Guideline for Management of Pediatric Patients with Acute Hematogenous Osteomyelitis

January 20, 2022

In this podcast episode, our content matter expert discusses what makes the recently published clinical practice guideline for the diagnosis and treatment of acute hematogenous osteomyelitis (AHO) in children unique and shares recommendations that could be practice changing at many facilities.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

2022 ASHP/ASHP Foundation Pharmacy Forecast

2022 ASHP/ASHP Foundation Pharmacy Forecast

January 14, 2022

Drs. Joseph DiPiro, Binita Patel, and Francesca Cunningham discuss the 2022 ASHP/ASHP Foundation Pharmacy Forecast Report, from its development to its impact, with host and AJHP Editor in Chief Daniel Cobaugh.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Become a Wiz at Urine Drug Screens (UDS)

Become a Wiz at Urine Drug Screens (UDS)

January 13, 2022

This podcast episode identifies what urine drug screens (UDS) can and cannot reveal and discusses different UDS results that may be available in your institution. Speakers will also touch on common misinterpretations when reviewing UDS screening results. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ISMP Targeted Medication Safety Best Practices for Hospitals #7 - neuromuscular blocking agents (NMB)

ISMP Targeted Medication Safety Best Practices for Hospitals #7 - neuromuscular blocking agents (NMB)

January 12, 2022

Learn about implementation of ISMP targeted medication safety best practices for hospital #7 that states to segregate, sequester, and differentiate all neuromuscular blocking agents (NMBs) from other medications, wherever they are stored in the organization. Faculty will provide tips on implementing this best practice and how to ‘”hardwire” this into health system practices.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Community Pharmacy: The Path to Leadership

Community Pharmacy: The Path to Leadership

January 11, 2022

In this podcast we discuss with Dr. Andrea Luebchow, Program  Director II of Community Pharmacy Services at Atrium Health Wake Forest Baptist. Dr. Luebchow discusses her current role, responsibilities, as well as her leadership journey from retail to health-systems community pharmacy practice. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

 

International Pharmacy Leadership

International Pharmacy Leadership

January 10, 2022

In this episode of Pharmacy Leadership, Vicki Basalyga sits down with Doug Slain to discuss his experiences as an international Antibiotic Stewarship Consultant and his involvement with U.S.-Thai Consortium for the Development of Pharmacy Education in Thailand and the unique leadership opportunities offered in these roles. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy Informatics Women Leaders: Distinguished Service

Pharmacy Informatics Women Leaders: Distinguished Service

January 7, 2022

Listeners will learn about SOPIT’s pharmacy informaticist women leaders who are recipients of the Distinguished Service Award for service to the Section and ASHP as demonstrated by sustained contributions and activities that support ASHP's mission and vision and advance the profession. Discussion will involve their career paths, current or past activities they most enjoyed, and where they envision informatics in the future.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Alcohol Withdrawal Management in the Emergency Department

Alcohol Withdrawal Management in the Emergency Department

January 6, 2022

EM Pharmacists and Physicians are in a unique position where they are able to see every stage of alcohol withdrawal arrive in the emergency department. With this setting, EM Pharmacists and Physicians have the ability to dramatically impact the course of a patient’s hospitalization or ED visit. This podcast episode will critically evaluate the monitoring and management of patients in alcohol withdrawal, specifically from the emergency department perspective. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.